March 12, 2019 Clinical Research/Diagn. M&A, Partnerships

Crown Bioscience Inc. and Charles River Laboratories Enter Agreement to Expand Access to ZDSD Rat Model

San Diego, Calif. and Wilmington, Mass. – March 12, 2019 – Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research today announced a licensing agreement with Charles River Laboratories International, Inc.’s Research Models and Services business. The agreement, designed to expand access to... Read more

March 1, 2019 Clinical Research/Diagn. M&A, Partnerships

Crown Bioscience and The Jackson Laboratory Collaboration Enables Global Access to FATZO Mouse

Continued Collaboration Facilitates Global Distribution of Obesity, Metabolic Disease, and NASH Model and Priority Supply to CrownBio’s World-Class Cardiovascular, Obesity, and Metabolic Disease Platform San Diego, Calif. – March 5, 2019 – Crown Bioscience, a global drug discovery and development services company, providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research today announced... Read more

December 13, 2018 Cell Analysis Tools Clinical Research/Diagn. Life Science Tools

Crown Bioscience Creates Center of Excellence for Bioinformatics, Big Data, and Biomarker Discovery Services

December 18, 2018 ~ Services and Capacity Increase with New Site Opening ~ (San Diego, Calif., December 13, 2018) — Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, has recently announced the expansion of its existing translational oncology research capacity by opening... Read more

October 25, 2018 Clinical Research/Diagn. Informatics & Software Product Launch

CrownBio Releases MuBase® 2.0. An Open Access Database of Immuno-Oncology Murine Models

October 25, 2018 Updates enhance user experience, provide comprehensive characterization data, and add new models (San Diego, Calif., Oct. 25 2018) — Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, has released MuBase 2.0. MuBase is CrownBio’s proprietary, free-to-access online database featuring... Read more